Skip to content
6-K

Foreign Interim / Material

Forward Pharma A/S

0001104659-21-125393

← back to feed
Filed
Oct 12, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Current Liabilities Q2 2021 · Jun 30, 2021 $587K
Current Liabilities Q2 2021 · Dec 31, 2020 $1.07M
Current Assets Q2 2021 · Jun 30, 2021 $75.69M
Current Assets Q2 2021 · Dec 31, 2020 $79.71M
Total Assets Q2 2021 · Jun 30, 2021 $75.7M
Total Assets Q2 2021 · Dec 31, 2020 $79.71M
Shares Diluted Q2 2021 · Jun 30, 2020 95.5M sh
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$1.91M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $75.63M
Cash And Equivalents Q2 2021 · Dec 31, 2019 $77.6M
Stockholders Equity Q2 2021 · Jun 30, 2020 $75.48M
Stockholders Equity Q2 2021 · Dec 31, 2019 $77.57M
Rd Expense Q2 2021 · Jun 30, 2020 $235K
Net Income Q2 2021 · Jun 30, 2020 −$2.26M
Operating Income Q2 2021 · Jun 30, 2020 −$2.02M